ALVO Alvotech
Healthcare$3.34-1.18%ClosedMarket Cap: $1.04B
As of 2026-05-25
Valuation
P/E (TTM)
40.46
PEG
0.36
P/B
-3.91
P/S
1.86
EV/EBITDA
-62.24
DCF Value
$-341.28
FCF Yield
-16.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.4%
Operating Margin
13.8%
Net Margin
-14.4%
ROE
35.2%
ROA
-5.7%
ROIC
-11.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $105.9M | 56.5% | $9.6M | $1.0M | $— | — |
| Q4 null | $166.4M | 63.2% | $48.2M | $-108.6M | $— | — |
| FY null | $586.3M | 59.8% | $78.2M | $27.9M | $— | — |
| Q3 null | $114.0M | 69.3% | $1.4M | $-5.2M | $— | — |
| Q2 null | $173.2M | 57.4% | $18.1M | $32.0M | $— | — |
| Q1 null | $132.8M | 50.7% | $10.6M | $109.7M | $— | — |
| Q4 null | $151.2M | 46.9% | $13.5M | $-67.0M | $— | — |
| FY null | $489.7M | 62.2% | $69.6M | $-231.9M | $— | — |
| Q3 null | $102.9M | 61.3% | $12.7M | $-11.4M | $— | — |
| Q2 null | $198.8M | 77.3% | $91.9M | $65.2M | $— | — |
| Q1 null | $36.9M | 45.8% | $-48.4M | $-218.7M | $— | — |
| Q4 2023 | $53.4M | -5.7% | $-79.0M | $-276.6M | $-1.04 | — |